1
Clinical Trials associated with Autologous Dendritic Cell vaccine(Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS)Complementary Vaccination With Dendritic Cells Pulsed With Autologous Tumor Lysate in Resected Stage III and IV Melanoma Patients: a Phase II Randomized Trial (ACDC Adjuvant Trial)
This phase II, randomized, open-label trial aims to assess whether the vaccination increase RFS in disease free melanoma patients after surgery. Patients will be randomized between Intradermal Autologous Dendritic Cell Vaccine loaded with autologous tumor lysate or homogenate (6 vaccines every 4 weeks) and observation.
100 Clinical Results associated with Autologous Dendritic Cell vaccine(Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS)
100 Translational Medicine associated with Autologous Dendritic Cell vaccine(Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS)
100 Patents (Medical) associated with Autologous Dendritic Cell vaccine(Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS)
100 Deals associated with Autologous Dendritic Cell vaccine(Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS)